These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 28881738)
1. Expression analysis of microRNA as prognostic biomarkers in colorectal cancer. Yang J; Ma D; Fesler A; Zhai H; Leamniramit A; Li W; Wu S; Ju J Oncotarget; 2017 Aug; 8(32):52403-52412. PubMed ID: 28881738 [TBL] [Abstract][Full Text] [Related]
2. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation. Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524 [TBL] [Abstract][Full Text] [Related]
4. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Nakajima G; Hayashi K; Xi Y; Kudo K; Uchida K; Takasaki K; Yamamoto M; Ju J Cancer Genomics Proteomics; 2006 Oct; 3(5):317-324. PubMed ID: 18172508 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955 [TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693 [TBL] [Abstract][Full Text] [Related]
7. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer. Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007 [TBL] [Abstract][Full Text] [Related]
8. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727 [TBL] [Abstract][Full Text] [Related]
9. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients. Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363 [TBL] [Abstract][Full Text] [Related]
10. miRNA expression patterns in chemoresistant breast cancer tissues. Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164 [TBL] [Abstract][Full Text] [Related]
11. Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g. Salendo J; Spitzner M; Kramer F; Zhang X; Jo P; Wolff HA; Kitz J; Kaulfuß S; Beißbarth T; Dobbelstein M; Ghadimi M; Grade M; Gaedcke J Radiother Oncol; 2013 Sep; 108(3):451-7. PubMed ID: 23932154 [TBL] [Abstract][Full Text] [Related]
12. [Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer]. Shikeeva AA; Kekeeva TV; Zavalishina LE; Andreeva YY; Zaletaev DV; Frank GA Arkh Patol; 2016; 78(3):3-10. PubMed ID: 27296000 [TBL] [Abstract][Full Text] [Related]
13. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793 [TBL] [Abstract][Full Text] [Related]
14. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501 [TBL] [Abstract][Full Text] [Related]
15. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
18. Identification of reference miRNAs in human tumors by TCGA miRNA-seq data. Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Chen L; Jin Y; Qiao Y; Shi Y; Wang Q Biochem Biophys Res Commun; 2014 Oct; 453(3):375-8. PubMed ID: 25264191 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2. Wu H; Liang Y; Shen L; Shen L Biol Open; 2016 May; 5(5):563-70. PubMed ID: 27095441 [TBL] [Abstract][Full Text] [Related]